Pharmaceutical companies are in a fierce competition to match the success of industry leaders Eli Lilly and Novo Nordisk in the weight-loss drug sector. The current focus is on enhancing the patient experience.
While the demand for these new weight-loss medications is high, there are notable challenges. Patients often face the inconvenience of weekly injections. Additionally, there are undesirable side effects such as gastrointestinal discomfort and the potential for muscle and bone loss.
This competitive environment drives drugmakers to develop improved alternatives that address these issues, aiming to offer more effective and patient-friendly solutions.
Increased Funding Needed for Psychiatric Hospitals 
Trump Administration Distributes ACA Refund Checks 
Higher Consumption of Ultra-Processed Foods Linked to Increased Health Risks 
Understanding Inflammation: Myths and Facts 
Calm Parenting: Strategies to Manage Stress 
Trump’s Executive Order to Combat Mosquitoes and Ticks in D.C.